Evidence map›Paper›PMID 28546748›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2017

Bronchiectasis in COPD patients: more than a comorbidity?

Miguel Angel Martinez-Garcia, Marc Miravitlles

Erratum issued 2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 4 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04215172 unknown statusnot on this mapstarted 2020, after this paper: background citation

Safety and Efficacy of Long-Term Macrolide Therapy in Patients With COPD-Bronchiectasis Overlap Syndrome

TypeobservationalSponsorAssiut UniversityRan2020 to 2022Enrolled60ConditionsBronchiectasisArmsMacrolides
NCT06346938 recruitingnot on this mapstarted 2024, after this paper: background citation

The Clinical Significance of CT-based Biomarkers in the Classification and Prognosis of Bronchiectasis

TypeobservationalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2024 to 2027Enrolled300ConditionsBronchiectasis
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 4 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Long-Term Risk of Mortality Associated with Isolation ofInternational journal of chronic obstructive pulmonary disease
    Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Inhaled Corticosteroid Use and Risk ofJournal of clinical medicine · 2025
    Article
  13. Article
  14. Inhaled Corticosteroids and Risk ofJournal of clinical medicine · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Miguel Angel Martinez-GarciaPneumology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Marc MiravitllesCIBER de Enfermedades Respiratorias (CIBERES), Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computed tomography scan images have been used to identify different radiological COPD phenotypes based on the presence and severity of emphysema, bronchial wall thickening, and bronchiectasis. Bronchiectasis is defined as an abnormal dilation of the bronchi, usually as a result of chronic airway inflammation and/or infection. The prevalence of bronchiectasis in patients with COPD is high, especially in advanced stages. The identification of bronchiectasis in COPD has been defined as a different clinical COPD phenotype with greater symptomatic severity, more frequent chronic bronchial infection and exacerbations, and poor prognosis. A causal association has not yet been proven, but it is biologically plausible that COPD, and particularly the infective and exacerbator COPD phenotypes, could be the cause of bronchiectasis without any other known etiology, beyond any mere association or comorbidity. The study of the relationship between COPD and bronchiectasis could have important clinical implications, since both diseases have different and complementary therapeutic approaches. Longitudinal studies are needed to investigate the development of bronchiectasis in COPD, and clinical trials with treatments aimed at reducing bacterial loads should be conducted to investigate their impact on the reduction of exacerbations and improvements in the long-term evolution of the disease.

Indexed as

LungAdultAgedAged, 80 and overBronchiectasisComorbidityFemaleHumansMaleMiddle AgedPhenotypePrevalencePrognosisPulmonary Disease, Chronic ObstructiveRisk FactorsTomography, X-Ray Computedbronchiectasisclinical phenotypeCOPDexacerbationsinfectionnatural history

Identifiers

PMID28546748
PMCPMC5436792
OpenAlexW2613303203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.